(25R)-3beta-[4-O-[4-O-(alpha-L-Rhamnopyranosyl)-alpha-L-rhamnopyranosyl]-beta-D-glucopyranosyloxy]spirosta-5-ene

Details

Top
Internal ID 530ed2df-8ab4-4b46-b30d-c95b519992a5
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal glycosides > Steroidal saponins
IUPAC Name (2S,3R,4R,5R,6S)-2-[(2S,3R,4S,5R,6S)-6-[(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(1S,2S,4S,5'R,6R,7S,8R,9S,12S,13R,16S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-16-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-methyloxan-3-yl]oxy-6-methyloxane-3,4,5-triol
SMILES (Canonical) CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)OC9C(C(C(C(O9)C)O)O)O)O)O)O)O)C)C)C)OC1
SMILES (Isomeric) C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O)O)O)O)O)O)C)C)C)OC1
InChI InChI=1S/C45H72O16/c1-19-9-14-45(54-18-19)20(2)30-28(61-45)16-27-25-8-7-23-15-24(10-12-43(23,5)26(25)11-13-44(27,30)6)57-42-37(53)34(50)39(29(17-46)58-42)60-41-36(52)33(49)38(22(4)56-41)59-40-35(51)32(48)31(47)21(3)55-40/h7,19-22,24-42,46-53H,8-18H2,1-6H3/t19-,20+,21+,22+,24+,25-,26+,27+,28+,29-,30+,31+,32-,33+,34-,35-,36-,37-,38+,39-,40+,41+,42-,43+,44+,45-/m1/s1
InChI Key CLBAIZZJADAEOT-ZVWYDXNDSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C45H72O16
Molecular Weight 869.00 g/mol
Exact Mass 868.48203620 g/mol
Topological Polar Surface Area (TPSA) 236.00 Ų
XlogP 1.30
Atomic LogP (AlogP) 1.24
H-Bond Acceptor 16
H-Bond Donor 8
Rotatable Bonds 7

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (25R)-3beta-[4-O-[4-O-(alpha-L-Rhamnopyranosyl)-alpha-L-rhamnopyranosyl]-beta-D-glucopyranosyloxy]spirosta-5-ene

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.6670 66.70%
Caco-2 - 0.8853 88.53%
Blood Brain Barrier - 0.6000 60.00%
Human oral bioavailability - 0.7714 77.14%
Subcellular localzation Mitochondria 0.7312 73.12%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9009 90.09%
OATP1B3 inhibitior + 0.9077 90.77%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.6000 60.00%
BSEP inhibitior + 0.8638 86.38%
P-glycoprotein inhibitior + 0.7307 73.07%
P-glycoprotein substrate + 0.5149 51.49%
CYP3A4 substrate + 0.7432 74.32%
CYP2C9 substrate - 0.8054 80.54%
CYP2D6 substrate - 0.8216 82.16%
CYP3A4 inhibition - 0.9365 93.65%
CYP2C9 inhibition - 0.9317 93.17%
CYP2C19 inhibition - 0.9163 91.63%
CYP2D6 inhibition - 0.9298 92.98%
CYP1A2 inhibition - 0.8611 86.11%
CYP2C8 inhibition + 0.7355 73.55%
CYP inhibitory promiscuity - 0.8619 86.19%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.4702 47.02%
Eye corrosion - 0.9888 98.88%
Eye irritation - 0.9131 91.31%
Skin irritation - 0.5365 53.65%
Skin corrosion - 0.9419 94.19%
Ames mutagenesis - 0.9670 96.70%
Human Ether-a-go-go-Related Gene inhibition + 0.8076 80.76%
Micronuclear - 0.8700 87.00%
Hepatotoxicity - 0.9875 98.75%
skin sensitisation - 0.9151 91.51%
Respiratory toxicity + 0.7556 75.56%
Reproductive toxicity + 0.8111 81.11%
Mitochondrial toxicity - 0.5375 53.75%
Nephrotoxicity - 0.8243 82.43%
Acute Oral Toxicity (c) III 0.4854 48.54%
Estrogen receptor binding + 0.8654 86.54%
Androgen receptor binding + 0.7125 71.25%
Thyroid receptor binding - 0.5459 54.59%
Glucocorticoid receptor binding + 0.6092 60.92%
Aromatase binding + 0.6833 68.33%
PPAR gamma + 0.7685 76.85%
Honey bee toxicity - 0.5556 55.56%
Biodegradation - 0.7500 75.00%
Crustacea aquatic toxicity - 0.5300 53.00%
Fish aquatic toxicity + 0.9347 93.47%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 98.55% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.24% 91.11%
CHEMBL226 P30542 Adenosine A1 receptor 96.82% 95.93%
CHEMBL3137262 O60341 LSD1/CoREST complex 94.45% 97.09%
CHEMBL1994 P08235 Mineralocorticoid receptor 93.82% 100.00%
CHEMBL1806 P11388 DNA topoisomerase II alpha 91.19% 89.00%
CHEMBL253 P34972 Cannabinoid CB2 receptor 90.87% 97.25%
CHEMBL5608 Q16288 NT-3 growth factor receptor 89.98% 95.89%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 89.50% 95.89%
CHEMBL1914 P06276 Butyrylcholinesterase 88.06% 95.00%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 87.04% 94.45%
CHEMBL4681 P42330 Aldo-keto-reductase family 1 member C3 86.45% 89.05%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 86.29% 95.50%
CHEMBL1293249 Q13887 Kruppel-like factor 5 86.00% 86.33%
CHEMBL218 P21554 Cannabinoid CB1 receptor 85.67% 96.61%
CHEMBL5255 O00206 Toll-like receptor 4 84.23% 92.50%
CHEMBL2274 Q9H228 Sphingosine 1-phosphate receptor Edg-8 83.47% 100.00%
CHEMBL2288 Q13526 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 81.80% 91.71%
CHEMBL237 P41145 Kappa opioid receptor 81.49% 98.10%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 81.25% 94.00%
CHEMBL2581 P07339 Cathepsin D 81.12% 98.95%
CHEMBL2373 P21730 C5a anaphylatoxin chemotactic receptor 80.99% 92.62%

Cross-Links

Top
PubChem 21603983
NPASS NPC251132
LOTUS LTS0253696
wikiData Q104963147